Research programme: rheumatoid arthritis therapy - elbion NV

Drug Profile

Research programme: rheumatoid arthritis therapy - elbion NV

Alternative Names: elbion NV-RA

Latest Information Update: 20 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator elbion NV
  • Class
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 20 Jul 2010 Discontinued - Preclinical for Rheumatoid arthritis in Belgium (unspecified route)
  • 14 Nov 2008 Biotie Therapies acquires elbion NV
  • 05 Dec 2006 4AZA Bioscience has merged with elbion to form elbion NV
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top